Escitalopram oxalate

Known as: 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1) 
The oxalate salt of escitalopram, a pure S-enantiomer of the racemic bicyclic phthalane derivative citalopram, with antidepressant activity. As a… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2018
024619892018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
IMPORTANCE Short-term studies suggest antidepressants are associated with modest weight gain but little is known about longer… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
IMPORTANCE Currently, fewer than 40% of patients treated for major depressive disorder achieve remission with initial treatment… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
The objective of the current study was to develop a validated, specific stability-indicating reversed-phase liquid… (More)
  • figure 1
  • table I
  • figure 2
  • table II
  • table III
Is this relevant?
2013
2013
IMPORTANCE Major depressive disorder develops in up to half the patients undergoing treatment for head and neck cancer, resulting… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2010
2010
A new, simple, fast and reliable zero order spectrophotometric method has been developed for determination of Escitalopram… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
A colorimetric method for the analysis of escitalopram oxalate in pure form and in tablets has been developed based on the… (More)
  • table 1
Is this relevant?
2009
2009
A simple, accurate and precise spectrophotometric method has been developed for simultaneous estimation of escitalopram oxalate… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2008
2008
CONTEXT Insomnia and generalized anxiety disorder (GAD) are prevalent disorders that may coexist. OBJECTIVE To determine the… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2008
2007
2007
The title compound {systematic name: (+)-(S)-3-[5-cyano-2(4̄uorophenyl)-1,3-dihydroisobenzofuran-2yl]propanaminium oxalate oxalic… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?